A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: A Gynecologic Oncology Group study
- 31 March 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 44 (3) , 268-270
- https://doi.org/10.1016/0090-8258(92)90055-n
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phase I/II Study of Definitive Radiotherapy and Chemotherapy (Cisplatin and 5-Fluorouracil) for Advanced or Recurrent Gynecologic MalignanciesAmerican Journal of Clinical Oncology, 1989
- A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A gynecologic oncology group studyGynecologic Oncology, 1989
- Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptideEuropean Journal of Cancer and Clinical Oncology, 1988
- A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervixAmerican Journal of Obstetrics and Gynecology, 1988
- DIDEMNIN B–AN IMMUNOSUPPRESSIVE CYCLIC PEPTIDE THAT STIMULATES MURINE HEMAGGLUTINATING ANTIBODY RESPONSES AND INDUCES LEUKOCYTOSIS IN VIVOTransplantation, 1987
- DIDEMNIN BTransplantation, 1985
- Didemnins: Antiviral and Antitumor Depsipeptides from a Caribbean TunicateScience, 1981